Walgreens Boots Alliance Inc (NASDAQ:WBA) announced a quarterly dividend on Friday, January 19th, Wall Street Journal reports. Stockholders of record on Thursday, February 15th will be given a dividend of 0.40 per share by the pharmacy operator on Monday, March 12th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date of this dividend is Wednesday, February 14th.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at $76.47 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The firm has a market capitalization of $75,290.84, a price-to-earnings ratio of 21.12, a PEG ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance has a 52-week low of $63.82 and a 52-week high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.10 EPS. research analysts expect that Walgreens Boots Alliance will post 5.71 earnings per share for the current fiscal year.

In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director John Anthony Lederer acquired 20,000 shares of the firm’s stock in a transaction dated Thursday, October 26th. The stock was bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. Insiders own 14.80% of the company’s stock.

A number of research firms have recently weighed in on WBA. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a research report on Saturday, January 13th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Needham & Company LLC reissued a “buy” rating and issued a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. Pivotal Research set a $73.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Friday, January 5th. Finally, ValuEngine raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Thursday, January 4th. Nine investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $86.20.

Walgreens Boots Alliance announced that its board has authorized a share buyback program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase programs are often a sign that the company’s board of directors believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: This report was first reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-announces-quarterly-dividend-of-0-40/1815363.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Dividend History for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.